Anti-PDHX monoclonal antibody
Pre-made anti-PDHX monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research
Go to PDHX/PDHX products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-IP2648-Ab-1/ GM-Tg-hg-IP2648-Ab-2 | Anti-Human PDHX monoclonal antibody | Human |
GM-Tg-rg-IP2648-Ab-1/ GM-Tg-rg-IP2648-Ab-2 | Anti-Rat PDHX monoclonal antibody | Rat |
GM-Tg-mg-IP2648-Ab-1/ GM-Tg-mg-IP2648-Ab-2 | Anti-Mouse PDHX monoclonal antibody | Mouse |
GM-Tg-cynog-IP2648-Ab-1/ GM-Tg-cynog-IP2648-Ab-2 | Anti-Cynomolgus/ Rhesus macaque PDHX monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-IP2648-Ab-1/ GM-Tg-felg-IP2648-Ab-2 | Anti-Feline PDHX monoclonal antibody | Feline |
GM-Tg-cang-IP2648-Ab-1/ GM-Tg-cang-IP2648-Ab-2 | Anti-Canine PDHX monoclonal antibody | Canine |
GM-Tg-bovg-IP2648-Ab-1/ GM-Tg-bovg-IP2648-Ab-2 | Anti-Bovine PDHX monoclonal antibody | Bovine |
GM-Tg-equg-IP2648-Ab-1/ GM-Tg-equg-IP2648-Ab-2 | Anti-Equine PDHX monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-IP2648-Ab-1/ GM-Tg-hg-IP2648-Ab-2; GM-Tg-rg-IP2648-Ab-1/ GM-Tg-rg-IP2648-Ab-2; GM-Tg-mg-IP2648-Ab-1/ GM-Tg-mg-IP2648-Ab-2; GM-Tg-cynog-IP2648-Ab-1/ GM-Tg-cynog-IP2648-Ab-2; GM-Tg-felg-IP2648-Ab-1/ GM-Tg-felg-IP2648-Ab-2; GM-Tg-cang-IP2648-Ab-1/ GM-Tg-cang-IP2648-Ab-2; GM-Tg-bovg-IP2648-Ab-1/ GM-Tg-bovg-IP2648-Ab-2; GM-Tg-equg-IP2648-Ab-1/ GM-Tg-equg-IP2648-Ab-2 |
Products Name | Anti-PDHX monoclonal antibody |
Format | mab |
Target Name | PDHX |
Protein Sub-location | Introcelluar Protein |
Category of antibody | |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected. |
Tag | Fc |
Products description | Pre-made anti-PDHX monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | GM-Tg-g-IP2648-Ag-1 | Recombinant multi-species ODPX/ PDHX/ DLDBP protein |
ORF Viral Vector | pGMLPm002769 | mouse Pdhx Lentivirus plasmid |
ORF Viral Vector | vGMLPm002769 | mouse Pdhx Lentivirus particle |
Target information
Target ID | GM-IP2648 |
Target Name | PDHX |
Gene ID | 8050,27402,311254,717932,475942,101095373,517402,100059260 |
Gene Symbol and Synonyms | Ac1164,DLDBP,E3BP,OPDX,PDHX,PDHXD,PDX1,proX |
Uniprot Accession | O00330,P22439 |
Uniprot Entry Name | ODPX_HUMAN,ODPX_BOVIN |
Protein Sub-location | Introcelluar Protein |
Category | |
Disease | N/A |
Gene Ensembl | ENSG00000110435 |
Target Classification | N/A |
The target: PDHX, gene name: PDHX, also named as DLDBP, E3BP, OPDXD, PDX1, proX, PDHX. The pyruvate dehydrogenase (PDH) complex is located in the mitochondrial matrix and catalyzes the conversion of pyruvate to acetyl coenzyme A. The PDH complex thereby links glycolysis to Krebs cycle. The PDH complex contains three catalytic subunits, E1, E2, and E3, two regulatory subunits, E1 kinase and E1 phosphatase, and a non-catalytic subunit, E3 binding protein (E3BP). This gene encodes the E3 binding protein subunit; also known as component X of the pyruvate dehydrogenase complex. This protein tethers E3 dimers to the E2 core of the PDH complex. Defects in this gene are a cause of pyruvate dehydrogenase deficiency which results in neurological dysfunction and lactic acidosis in infancy and early childhood. This protein is also a minor antigen for antimitochondrial antibodies. These autoantibodies are present in nearly 95% of patients with the autoimmune liver disease primary biliary cirrhosis (PBC). In PBC, activated T lymphocytes attack and destroy epithelial cells in the bile duct where this protein is abnormally distributed and overexpressed. PBC eventually leads to cirrhosis and liver failure. Alternative splicing results in multiple transcript variants encoding distinct isoforms.[provided by RefSeq, Oct 2009].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.